Premium
BRCA1 expression in leukoplakia and carcinoma of the tongue
Author(s) -
Vora Hemangini H.,
Shah Neelam G.,
Patel Devendra D.,
Trivedi Trupti I.,
Choksi Tejal J.
Publication year - 2003
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.10213
Subject(s) - medicine , tongue , leukoplakia , immunohistochemistry , staining , pathology , carcinoma , cancer , tongue neoplasm , dysplasia , survival analysis
Background and Objectives Expression of BRCA1 was examined in patients with leukoplakia and carcinoma of the tongue. Its prognostic value was evaluated in patients with tongue cancer. Methods Expression of BRCA1 was studied by immunohistochemical localization. Cytoplasmic staining of BRCA1 was observed in both leukoplakia and carcinoma of the tongue. Results In leukoplakia, 61% and 39% of the patients expressed BRCA1 expression with a staining intensity of 1+ and 2+, respectively. In patients with hyperplasia (67%), BRCA1 expression with a staining intensity of 1+ was 67%; BRCA1 expression with a staining intensity of 2+ was 33%. In patients with dysplasia (33%; mild and moderate), BRCA1 expression with a staining intensity of 1+ and 2+ was 50% each. In carcinoma of the tongue, only 34% of the patients showed BRCA1 expression. In this group, 33% of the tumors exhibited 1+ staining, and only 1% of the tumors expressed 2+ staining. Moreover, BRCA1 expression with a staining intensity of 2+ was significantly higher in patients with dysplasia (50%) than in those with hyperplasia (33%), followed by patients with squamous cell carcinoma of the tongue (1%). The percentage positivity of BRCA1 expression in tongue cancer patients was significantly lower (34%), as compared with patients with leukoplakia (100%; P = 0.1). A significant positive correlation was noted between BRCA1 and c‐ myc ( P = 0.012). Univariate survival analysis by log‐rank test and multivariate survival analysis by Cox regression showed that BRCA1 expression was the most significant prognostic factor predicting relapse‐free survival of early‐stage patients. Conclusions Subcellular localization of the BRCA1 gene product provided evidence of its involvement in the pathogenesis of tongue tumors. J. Surg. Oncol. 2003;83:232–240. © 2003 Wiley‐Liss, Inc.